BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26556869)

  • 21. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL).
    Fischer L; Hummel M; Burmeister T; Schwartz S; Thiel E
    Hematol Oncol; 2006 Jun; 24(2):78-85. PubMed ID: 16598823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Flow-Cytometry-Based Immunophenotyping Analysis for Accurate Diagnosis and Management of Extranodal NK/T Cell Lymphoma, Nasal Type.
    Wang JC; Deng XQ; Liu WP; Gao LM; Zhang WY; Yan JQ; Ye YX; Liu F; Zhao S
    Cytometry B Clin Cytom; 2020 Jan; 98(1):28-35. PubMed ID: 31313887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.
    Olteanu H; Schur BC; Bredeson C; Atallah E; Kroft SH
    Leuk Lymphoma; 2010 Mar; 51(3):481-7. PubMed ID: 20141431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
    Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F
    Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the brazilian group of flow cytometry (GBCFLUX).
    Sales MM; Ferreira SIACP; Ikoma MRV; Sandes AF; Beltrame MP; Bacal NS; Silva MCA; Malvezzi M; Lorand-Metze IGH; Orfao A; Yamamoto M;
    Cytometry B Clin Cytom; 2017 Sep; 92(5):398-410. PubMed ID: 27362793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype.
    Pridgeon C; Lennon GP; Pazmany L; Thompson RN; Christmas SE; Moots RJ
    Rheumatology (Oxford); 2003 Jul; 42(7):870-8. PubMed ID: 12730548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation.
    Barilà G; Teramo A; Calabretto G; Ercolin C; Boscaro E; Trimarco V; Carraro S; Leoncin M; Vicenzetto C; Cabrelle A; Facco M; Piazza F; Semenzato G; Zambello R
    Blood Cancer J; 2018 Jun; 8(6):51. PubMed ID: 29891951
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical Experience With Modified, Single-Tube T-Cell Receptor Vβ Flow Cytometry Analysis for T-Cell Clonality.
    Wu D; Anderson MM; Othus M; Wood BL
    Am J Clin Pathol; 2016 Apr; 145(4):467-85. PubMed ID: 27149025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets.
    Flores-Montero J; Grigore G; Fluxá R; Hernández J; Fernandez P; Almeida J; Muñoz N; Böttcher S; Sedek L; van der Velden V; Barrena S; Hernández A; Paiva B; Lecrevisse Q; Lima M; Santos AH; van Dongen JJM; Orfao A
    J Immunol Methods; 2019 Dec; 475():112662. PubMed ID: 31454495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.
    Morice WG; Jevremovic D; Olteanu H; Roden A; Nowakowski G; Kroft S; Hanson CA; Kurtin PJ
    Leukemia; 2010 Apr; 24(4):881-4. PubMed ID: 20111066
    [No Abstract]   [Full Text] [Related]  

  • 34. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
    Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
    Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-Antibody Evaluation of T-Cell Receptor β Constant Chain Monotypia by Flow Cytometry Facilitates the Diagnosis of T-Cell Large Granular Lymphocytic Leukemia.
    Horna P; Olteanu H; Jevremovic D; Otteson GE; Corley H; Ding W; Parikh SA; Shah MV; Morice WG; Shi M
    Am J Clin Pathol; 2021 Jun; 156(1):139-148. PubMed ID: 33438036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.
    Basak PY; Adiloglu AK; Koc IG; Tas T; Akkaya VB
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):970-6. PubMed ID: 18482314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.
    Sekiguchi N; Nishina S; Kawakami T; Sakai H; Senoo N; Senoo Y; Ito T; Saito H; Nakazawa H; Koizumi T; Ishida F
    Int J Hematol; 2017 Jun; 105(6):854-858. PubMed ID: 28028749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
    Porwit A
    Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.